Clover Therapeutics discovers and develops precision medicines for diseases of aging with a genetics-driven approach. We have a genetically diverse, longitudinal, and re-contactable Medicare patient network with comprehensive clinical data as the foundation of our clinico-genomic studies. We are currently advancing preclinical drug programs in Age-related Macular Degeneration (AMD), and conducting two observational clinical studies in this disease.
Investors 3
| Date | Name | Website |
| - | MBC BioLab... | mbcbiolabs... |
| 20.07.2021 | Lifeforce ... | lifeforcec... |
| 11.08.2020 | Cantos Ven... | cantos.vc |
Mentions in press and media 3
| Date | Title | Description |
| 10.07.2019 | Medicare Advantage startup Clover Health launches drug development arm | The two organizations will work together on designing studies, collecting samples and analyzing resulting data. Cheng Zhang, the head of Clover Therapeutics, tied his group’s mission into the larger ambitions of Clover Health. Clover touts ... |
| - | Medicare Advantage startup Clover Health launches drug development arm | Medicare Advantage startup Clover Health has started a biopharmaceutical division called Clover Therapeutics meant to use data on the health plan’s members to help inform the development of new therapies for age-related chronic diseases. Th... |
| - | Character Biosciences | “Character Bio” |